Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

Pages

1:37pm

Fri January 10, 2014
Shots - Health News

Half Of A Drug's Power Comes From Thinking It Will Work

Originally published on Fri January 10, 2014 2:37 pm

iStockphoto

When you take a pill, you and your doctor hope it will work — and that helps it work.

That's not a new idea. But now researchers say they know just how much of a drug's effect comes from the patient's expectation: at least half.

When patients in the midst of a migraine attack took a dummy pill they thought was a widely used migraine drug, it reduced their pain roughly as much as when they took the real drug thinking it was a placebo.

Read more

5:03pm

Tue January 7, 2014
Shots - Health News

50 Years After Landmark Warning, 8 Million Fewer Smoking Deaths

Originally published on Wed January 8, 2014 2:22 pm

Tobacco companies incorporated doctors in their ads, such as this 1930 Lucky Strike campaign, to convince the public that smoking wasn't harmful.
Stanford University

Saturday marks an important milestone in public health – the 50th anniversary of the first Surgeon General's Report on Smoking and Health.

Few if any documents have had the impact of this one — both on the amount of disease and death prevented, and on the very scope of public health.

Read more

2:22am

Mon December 30, 2013
Shots - Health News

$1,000 Pill For Hepatitis C Spurs Debate Over Drug Prices

Originally published on Thu February 6, 2014 2:43 pm

Federal regulators this month opened a new era in the treatment of a deadly liver virus that infects three to five times more people than HIV. Now the question is: Who will get access to the new drug for hepatitis C, and when?

The drug Sovaldi will cost $1,000 per pill. A typical course of treatment will last 12 weeks and run $84,000, plus the cost of necessary companion drugs. Some patients may need treatment for twice as long.

Read more

9:03am

Sat December 7, 2013
Shots - Health News

Gene Therapy Keeps 'Bubble Boy' Disease At Bay In 8 Children

David Vetter was born without a functioning immune system and spent his life in a bubble that protected him from germs. He died at age 12 in 1984. Scientists are using gene therapy to treat the disorder so that children can live normally.
Science Source

Researchers say they are achieving success in curing the genetic defect that causes some children to be born without immune defenses, a rare condition made famous in the 1970s by a Texas boy who lived most of his short life in a sterile "bubble."

Scientists now report that 8 out of 9 young children given gene therapy for a type of severe combined immunodeficiency disease, called SCID-X1, are alive and living amid the everyday microbial threats that would otherwise have killed them. The oldest is just over 3 years old.

Read more

11:20am

Fri December 6, 2013
Shots - Health News

Hoped-For AIDS Cures Fail In 2 Boston Patients

Originally published on Fri December 6, 2013 12:15 pm

The HIV virus has proven once again that it can evade detection in the body.
BSIP UIG via Getty Images

HIV has reappeared in the blood of two Boston patients who scientists had hoped had been cured of their infections.

This disappointing development, reported by The Boston Globe's Kay Lazar, is yet another cautionary tale of how researchers can never afford to underestimate the human immunodeficiency virus's ability to hide out in patients' bodies and overcome their most ingenious efforts to eliminate it.

Read more

Pages